Assessing 4D Molecular Therapeutics: Insights From 5 Financial Analysts
Latest Ratings for FDMT Date Firm Action From To Jan 2022 SVB Leerink Initiates Coverage On Outperform Jan 2021 B of A Securities Initiates Coverage On Buy Jan 2021 Goldman Sachs Initiates Coverage On Neutral View More Analyst Ratings for FDMT View the Latest Analyst Ratings read more